Skip to main content

Table 1 Baseline characteristics of participants, stratified by NAFLD or MASLD status: NHANES III (1988–1994)

From: Association between atherogenic index of plasma and all-cause mortality and cardiovascular disease among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease

Characteristic

NAFLD

Non-NAFLD

P value

MASLD

Non-MASLD

P value

(n = 3233)

(n = 9696)

(n = 2799)

(n = 10130)

Age, years, mean (SD)

46.4 (15.55)

43.08 (16.03)

< 0.001

47.75 (15.17)

42.85 (16.03)

< 0.001

Male, n (%)

1620 (50.11)

4531 (46.73)

< 0.001

1450 (51.80)

4701 (46.41)

< 0.001

Race/ethnicity, n (%)

  

< 0.001

  

< 0.001

Non-Hispanic white

1215 (37.58)

3588 (37.00)

 

1064 (38.01)

3739 (36.91)

 

Non-Hispanic black

770 (23.82)

2916 (30.07)

 

628 (22.44)

3058 (30.19)

 

Mexican-American

1124 (34.77)

2772 (28.59)

 

1010 (36.08)

2886 (28.49)

 

Other race

124 (3.84)

420 (4.33)

 

97 (3.47)

447 (4.41)

 

Low income, n (%)

929 (31.21)

2913 (32.92)

0.084

801 (31.18)

3041 (32.85)

0.110

Married, n (%)

2185 (67.58)

6036 (62.25)

< 0.001

1936 (69.17)

6285 (62.04)

< 0.001

Education, n (%)

  

0.002

  

0.002

More than or equal to high school

2453 (76.16)

7584 (78.74)

 

2116 (75.92)

7921 (78.69)

 

Current smokers, n (%)

839 (25.95)

2824 (29.13)

< 0.001

695 (24.83)

2968 (29.30)

< 0.001

Sedentary lifestyle, n (%)

979 (30.28)

2818 (29.06)

0.188

849 (30.33)

2948 (29.10)

0.206

BMI, kg/m2, mean (SD)

28.50 (6.05)

26.13 (4.92)

< 0.001

29.28 (5.79)

26.01 (4.96)

< 0.001

WC, cm, mean (SD)

98.50 (15.88)

91.19 (13.72)

< 0.001

101.13 (14.27)

90.77 (13.93)

< 0.001

Diabetes, n (%)

455 (14.07)

702 (7.24)

< 0.001

414 (14.79)

743 (7.33)

< 0.001

Hypertension, n (%)

1314 (40.64)

2970 (30.63)

< 0.001

1240 (44.30)

3044 (30.05)

< 0.001

TG, mg/dL, mean(SD)

171.30 (122.89)

131.51 (100.64)

< 0.001

181.47 (125.09)

130.41 (100.02)

< 0.001

HDL-C, mg/dL, mean (SD)

47.91 (15.06)

51.80 (15.43)

< 0.001

46.76 (14.82)

51.95 (15.41)

< 0.001

HbA1c (%)

5.75 (1.37)

5.46 (1.02)

< 0.001

5.81 (1.37)

5.45 (1.03)

< 0.001

Glucose, mg/dL, mean(SD)

108.64 (47.28)

98.91 (32.42)

< 0.001

110.23 (48.19)

98.89 (32.75)

< 0.001

Insulin, uU/mL, mean (SD)

80.96 (70.00)

59.30 (50.94)

< 0.001

83.10 (71.25)

59.14 (50.74)

< 0.001

HOMA-IR, mean (SD)

378.91 (332.34)

266.26 (230.44)

< 0.001

388.04 (337.28)

266.22 (230.59)

< 0.001

NFS, mean (SD)

-1.89 (1.63)

-2.21 (1.61)

< 0.001

-1.77 (1.59)

-2.22 (1.61)

< 0.001

NFS > -1.455, n (%)

1159 (38.893)

2632 (29.666)

< 0.001

1075 (41.651)

2716 (29.296)

< 0.001

FIB-4, mean (SD)

1.01 (0.83)

0.95 (1.02)

< 0.001

1.02 (0.77)

0.95 (1.03)

< 0.001

FIB-4 > 1.3, n (%)

693 (21.868)

1820 (19.237)

0.001

626 (22.822)

1887 (19.086)

< 0.001

Heart attack (%)

136 (4.21)

297 (3.06)

0.002

125 (4.47)

308 (3.04)

< 0.001

Stroke (%)

71 (2.20)

163 (1.68)

0.057

64 (2.29)

170 (1.68)

0.033

Congresive heart failure (%)

112 (3.46)

243 (2.51)

0.004

99 (3.54)

256 (2.53)

0.004

Angina pectoris (%)

333 (10.30)

808 (8.33)

< 0.001

296 (10.58)

845 (8.34)

< 0.001

CVD (%)

485 (15.00)

1164 (12.00)

< 0.001

434 (15.51)

1215 (11.99)

< 0.001

All-cause mortality, n (%)

1184 (36.62)

2916 (30.07)

< 0.001

1076 (38.44)

3024 (29.85)

< 0.001

CVD mortality, n (%)

358 (11.07)

899 (9.27)

0.003

330 (11.79)

927 (9.15)

< 0.001

  1. *p-values were derived from a weighted Kruskal-Wallis test for continuous variables and a weighted rank sum test for categorical variables to compare the differences of each variable between groups
  2. NAFLD: Non-alcoholic fatty liver disease; MASLD: Metabolic dysfunction-associated steatotic liver disease; SD: Standard deviation; BMI: Body mass index; WC: Waist circumference; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; HbA1c: Hemoglobin A1c; HOMA-IR: Homeostasis Model Assessment of Insulin Resistance; NFS: Non-alcoholic fatty liver disease fibrosis score; FIB-4: Fibrosis-4 index; CVD: Cardiovascular disease